FEB 15, 2016 6:58 AM PST

Electronic "Nose" Detects Prostate Cancer from Urine

WRITTEN BY: Xuan Pham
Docs may soon diagnose prostate cancer by urine odor test

Scientists at the University of Liverpool recently unveiled an electronic “smell” test for prostate cancer detection. The test is an important leap forward, with the possibility of replacing traditional invasive diagnostic procedures that are currently in practice.
 
Prostate cancer represents a huge health risk for half the world’s population, as it is the most common form of cancer in men. Current detection methods include the wince-inducing digital rectal exam (DRE) and blood tests that measure prostate-specific antigen (PSA). However, prostate cancer can only be truly confirmed with invasive prostate biopsies.
 
"There is an urgent need to identify these cancers at an earlier stage when they are more treatable as the earlier a person is diagnosed the better,” said Professor Chris Probert, senior study author from the University of Liverpool.
 
PSA levels for healthy men are usually less than 4 nanograms per milliliter (ng/mL) of blood. However, having more or less PSA than that range doesn’t guarantee cancer or no cancer, respectively. Furthermore, PSA level cutoffs are not standardized, which contributes to increased cases of false negatives and false positives. “This can sometimes result in unnecessary biopsies, resulting in psychological toll, risk of infection from the procedure and even sometimes missing cancer cases,” said Professor Norman Ratcliffe, co-author of the study.
 
To be more precise at identifying prostate cancer while simultaneously being easier to perform and withstand, the research team developed the “Odoreader,” a gas-chromatography sensor that detects chemical patterns in urine. Likened to an electronic “nose,” the Odoreader has a 30-meter column through which urine samples get broken into their smaller chemical constituents. These “odor” patterns are then translated and matched, enabling cancer identification from the urine. 
 
 
In a pilot study with 155 men from urology clinics, the Odoreader diagnosed 58 men with prostate cancer, 24 men with bladder cancer, and 73 men with urinary problems unrelated to cancer. The team reported an impressive 95% sensitivity and 96% specificity after validation, showing that the system has both high accuracy and precision.
 
The sniff test could save men who test negative from undergoing invasive prostate biopsies. Conversely, positive cancer profiles in urine samples would alert doctors and crucial treatments could proceed without delay.
 
The team is excited about the success of the Odoreader and is already planning the next steps. “After further sample testing, the next step is to take this technology and put it into a user-friendly format. With help from industry partners we will be able to further develop the Odoreader, which will enable it to be used where it is needed most; at a patient's bedside, in a doctor's surgery, in a clinic or Walk In Centre, providing fast, inexpensive, accurate results," said Probert.

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 28, 2021
Clinical & Molecular DX
Black College Football Players More at Risk of Heart Conditions
SEP 28, 2021
Black College Football Players More at Risk of Heart Conditions
College football players may have an elevated risk of developing a heart condition where the left side of the heart beco ...
OCT 17, 2021
Technology
How Do People Feel About Facial Recognition Tools In Healthcare?
OCT 17, 2021
How Do People Feel About Facial Recognition Tools In Healthcare?
Facial image data and recognition tools have become a nearly ubiquitous part of our society: we use it to unlock smartph ...
NOV 15, 2021
Health & Medicine
Alpha-synuclein as a Biomarker for Parkinson's Disease
NOV 15, 2021
Alpha-synuclein as a Biomarker for Parkinson's Disease
Parkinson’s disease (PD) is a widespread neurogenerative disorder that can significantly impact a person’s q ...
NOV 19, 2021
Technology
Artificial Intelligence Could Predict Risk of Atrial Fibrillation
NOV 19, 2021
Artificial Intelligence Could Predict Risk of Atrial Fibrillation
Atrial fibrillation (AF) is a common heart condition—by 2030, the Centers for Disease Control estimates that nearl ...
DEC 24, 2021
Coronavirus
COVID-19 Tests & What to do About a Positive Result
DEC 24, 2021
COVID-19 Tests & What to do About a Positive Result
There are several types of tests for COVID-19. A laboratory test for SARS-CoV-2 (the virus that causes COVID-19) will te ...
JAN 05, 2022
Clinical & Molecular DX
Labroots 2021 Clinical Research & Diagnostics Virtual Event's Winning Poster
JAN 05, 2022
Labroots 2021 Clinical Research & Diagnostics Virtual Event's Winning Poster
The SARS-CoV-2 virus that emerged in December 2019 causes the disease COVID-19, a pandemic that has killed over 5 millio ...
Loading Comments...